NCT01673984 2025-05-23
GREAT
Ipsen
Phase 4 Terminated
Clinical Trials
4 trialsNCT00415246 2019-11-22
Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer
Ipsen
Phase 3 Terminated
NCT00444639 2019-11-22
Study to Assess the Non-inferiority of PamorelinĀ® 11,25mg SC Injected Versus PamorelinĀ® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)
Ipsen
Phase 2 Terminated
NCT01374087 2019-09-18
ANABRAQ
Ipsen
Phase 2 Terminated